VBP Pains Swell Prompting New China Strategy, Local Innovation Focus

Drug Makers Tap Into Local Innovation

 
• By Brian Yang

As the rollout of volume-based procurement to more products brings more pain, drug makers are exploring different China strategies. One indicator, though, is clear - local innovation and distribution can’t be ignored anymore.

China slowdown
China VBP pressure prompts big pharma to tap into local innovation in a strategy shift • Source: Shutterstock

More from China

More from Focus On Asia